Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy. 

Accept / Decline


Ferring Pharmaceuticals and Roche collaborate to develop personalised infertility treatment

Saint-Prex and Rotkreuz, Switzerland - 24 June 2014 – Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring’s human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development. This combination is intended to make it possible for healthcare professionals to personalise infertility treatment to a woman’s specific needs.

Click here to read more

See more Newsroom


Ferring Canada
200 Yorkland Boulevard, Suite 500
Toronto, Ontario, M2J 5C1 

Tel:  +1 416 490 0121 or +1 800 263 4057
Fax: 416 493 1692